Coronary heart disease - At the interface of molecular genetics and preventive medicine

被引:32
作者
Ellsworth, DL [1 ]
Sholinsky, P [1 ]
Jaquish, C [1 ]
Fabsitz, RR [1 ]
Manolio, TA [1 ]
机构
[1] NHLBI, Epidemiol & Biometry Program, Div Epidemiol & Clin Applicat, NIH, Bethesda, MD 20892 USA
关键词
cardiovascular diseases; coronary disease; polymorphism (genetics); pharmacogenetics; chemical and pharmacologic phenomena; risk factors;
D O I
10.1016/S0749-3797(98)00138-X
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Susceptibility to common chronic diseases such as coronary heart disease (CHD) appears to be influenced by "context-dependent effects," which include interactions among genes (genetic epistasis) and among genes and environmental factors (gene-environment interactions). Methods: A synthesis of current knowledge and research findings demonstrates the importance of integrating genetic research on cardiovascular disease with preventive medicine and public health initiatives. Results: A variety of candidate genes have been implicated in risk for CIID, but only limited examples of context-dependent effects have been described. Interactions between genetic and environmental factors appear to influence lipid metabolism, plasma homocysteine levels, and pharmacologic response to many commonly prescribed medications. Quantification of genetic effects associated with increased disease risk that are modifiable by interventions such, as diet, exercise, and smoking cessation is an important: interface between molecular genetics and preventive medicine. Conclusions: As a primary focus of preventive medicine expands to encompass early detection and treatment of asymptomatic individuals at risk for disease, the ability to quantify tie influence of context-dependent effects on disease risk will be critical for determining drug safety and effectiveness in diverse patient populations and for implementing effective prevention and treatment programs.
引用
收藏
页码:122 / 133
页数:12
相关论文
共 86 条
  • [1] AKULLU E, 1996, J PHARMACOL EXP THER, V278, P441
  • [2] CLINICAL-SIGNIFICANCE OF GENETIC INFLUENCES ON CARDIOVASCULAR DRUG-METABOLISM
    ARCAVI, L
    BENOWITZ, NL
    [J]. CARDIOVASCULAR DRUGS AND THERAPY, 1993, 7 (03) : 311 - 324
  • [3] RENIN AND ATRIAL-NATRIURETIC-PEPTIDE RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISMS - ASSOCIATION WITH ETHNICITY AND BLOOD-PRESSURE
    BARLEY, J
    CARTER, ND
    CRUICKSHANK, JK
    JEFFERY, S
    SMITH, A
    CHARLETT, A
    WEBB, DJ
    [J]. JOURNAL OF HYPERTENSION, 1991, 9 (11) : 993 - 996
  • [4] IDENTIFICATION AND MANAGEMENT OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA - SUMMARY AND RECOMMENDATIONS FROM AN NHLBI WORKSHOP
    BILD, DE
    WILLIAMS, RR
    BREWER, HB
    HERD, JA
    PEARSON, TA
    STEIN, E
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1993, 72 (10) : D1 - D5
  • [5] BLOEM LJ, 1993, HYPERTENSION, V22, P407
  • [6] BOERWINKLE E, 1988, AM J HUM GENET, V42, P104
  • [7] BOERWINKLE E, 1990, CURR OPIN LIPIDOL, V1, P151
  • [8] Ethical issues of genetic testing and their implications in epidemiologic studies
    Bondy, M
    Mastromarino, C
    [J]. ANNALS OF EPIDEMIOLOGY, 1997, 7 (05) : 363 - 366
  • [9] ANGIOTENSIN-II TYPE-1 RECEPTOR GENE POLYMORPHISMS IN HUMAN ESSENTIAL-HYPERTENSION
    BONNARDEAUX, A
    DAVIES, E
    JEUNEMAITRE, X
    FERY, I
    CHARRU, A
    CLAUSER, E
    TIRET, L
    CAMBIEN, F
    CORVOL, P
    SOUBRIER, F
    [J]. HYPERTENSION, 1994, 24 (01) : 63 - 69
  • [10] Familial resemblance for VO2max in the sedentary state:: the HERITAGE Family Study
    Bouchard, C
    Daw, EW
    Rice, T
    Pérusse, L
    Gagnon, J
    Province, MA
    Leon, AS
    Rao, DC
    Skinner, JS
    Wilmore, JH
    [J]. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 1998, 30 (02) : 252 - 258